Literature DB >> 1991084

Long-term efficacy of primary laser trabeculoplasty.

T Elsås1, H Johnsen.   

Abstract

Sixty glaucomatous eyes of 60 patients treated with laser trabeculoplasty as primary therapy were reviewed retrospectively. There were 42 eyes with capsular glaucoma and 18 with simple glaucoma. The mean prelaser intraocular pressure (IOP) was 35.2 (SD = 6.5) mmHg. Success was defined as IOP less than or equal to 22 mmHg without medication. The probability of success was 0.73 at 1 year, 0.66 at 2 years, 0.57 at 3 years, and 0.50 at 4 years. Three eyes experienced progressive visual field loss or disc damage in spite of an intraocular pressure below 22 mmHg without medication. High prelaser pressure and the severity of the visual field defects were significant predictors of treatment failure.

Entities:  

Mesh:

Year:  1991        PMID: 1991084      PMCID: PMC504103          DOI: 10.1136/bjo.75.1.34

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  22 in total

1.  Laser trabeculoplasty versus medication treatment as primary therapy for glaucoma.

Authors:  A Tuulonen; J Koponen; H I Alanko; P J Airaksinen
Journal:  Acta Ophthalmol (Copenh)       Date:  1989-06

2.  The immediate pressure response to primary laser trabeculoplasty--a comparison of one- and two-stage treatment.

Authors:  T Elsås; H Johnsen; T A Brevik
Journal:  Acta Ophthalmol (Copenh)       Date:  1989-12

3.  Long-term efficacy of argon laser trabeculoplasty.

Authors:  B J Shingleton; C U Richter; A R Bellows; B T Hutchinson; R J Glynn
Journal:  Ophthalmology       Date:  1987-12       Impact factor: 12.079

4.  A controlled five-year follow-up study of laser trabeculoplasty as primary therapy for open-angle glaucoma.

Authors:  A Tuulonen; A K Niva; H I Alanko
Journal:  Am J Ophthalmol       Date:  1987-10-15       Impact factor: 5.258

5.  Primary lasertrabeculoplasty a comparison of 50 spots in 180 degrees and 100 spots in 360 degrees of the trabecular meshwork.

Authors:  T Elsås
Journal:  Acta Ophthalmol (Copenh)       Date:  1987-06

6.  Cupping and pallor of the optic disc.

Authors:  B Schwartz
Journal:  Arch Ophthalmol       Date:  1973-04

7.  Control of chronic simple glaucoma with primary medical, surgical and laser treatment.

Authors:  C Migdal; R Hitchings
Journal:  Trans Ophthalmol Soc U K       Date:  1986

8.  Laser trabeculoplasty in glaucoma. Ten-year evaluation.

Authors:  U Ticho; R Nesher
Journal:  Arch Ophthalmol       Date:  1989-06

9.  Ten year results of laser trabeculoplasty. Does the laser avoid glaucoma surgery or merely defer it?

Authors:  J B Wise
Journal:  Eye (Lond)       Date:  1987       Impact factor: 3.775

10.  A review of surgical alternatives to medical therapy for glaucoma.

Authors:  D E Gaasterland
Journal:  J Natl Med Assoc       Date:  1988-07       Impact factor: 1.798

View more
  5 in total

Review 1.  The medical and surgical management of pseudoexfoliation glaucoma.

Authors:  Manishi A Desai; Richard K Lee
Journal:  Int Ophthalmol Clin       Date:  2008

2.  Efficacy of argon laser trabeculoplasty: 3-year preliminary results of a prospective placebo-controlled study.

Authors:  C Ustundag; M Diestelhorst
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-06       Impact factor: 3.117

Review 3.  Recent Advances in the Surgical Management of Glaucoma in Exfoliation Syndrome.

Authors:  Mohamed S Sayed; Richard K Lee
Journal:  J Glaucoma       Date:  2018-07       Impact factor: 2.503

Review 4.  Noninvasive glaucoma procedures: current options and future innovations.

Authors:  Ahmed M Abdelrahman
Journal:  Middle East Afr J Ophthalmol       Date:  2015 Jan-Mar

5.  European Glaucoma Society Terminology and Guidelines for Glaucoma, 4th Edition - Chapter 3: Treatment principles and options Supported by the EGS Foundation: Part 1: Foreword; Introduction; Glossary; Chapter 3 Treatment principles and options.

Authors: 
Journal:  Br J Ophthalmol       Date:  2017-06       Impact factor: 4.638

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.